You are on page 1of 5

DAFTAR PUSTAKA

1. World Health Organization. Cancer [Internet]. Cancer. 2021. Available from:


https://www.who.int/news-room/fact-sheets/detail/cancer
2. Nardi-Agmon I, Peled N. Exhaled breath analysis for the early detection of lung cancer:
recent developments and future prospects. LCTT. 2017 May 17;8:31–8.
3. Jia Z, Zhang H, Ong CN, Patra A, Lu Y, Lim CT, et al. Detection of Lung Cancer:
Concomitant Volatile Organic Compounds and Metabolomic Profiling of Six Cancer
Cell Lines of Different Histological Origins. ACS Omega. 2018 May 10;3(5):5131–40.
4. Jia Z, Patra A, Kutty VK, Venkatesan T. Critical Review of Volatile Organic Compound
Analysis in Breath and In Vitro Cell Culture for Detection of Lung Cancer. Metabolites.
2019 Mar 18;9(3):52.
5. Siddiqui F, Siddiqui AH. Lung Cancer. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing; 2021 [cited 2021 Oct 17]. Available from:
http://www.ncbi.nlm.nih.gov/books/NBK482357/
6. Corradi M, Poli D, Banda I, Bonini S, Mozzoni P, Pinelli S, et al. Exhaled breath
analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study. J
Breath Res. 2015 Jan 29;9(2):027101.
7. Schnabel R, Fijten R, Smolinska A, Dallinga J, Boumans M-L, Stobberingh E, et al.
Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-
associated pneumonia. Sci Rep. 2015 Nov 26;5(1):17179.
8. Capuano R, Santonico M, Pennazza G, Ghezzi S, Martinelli E, Roscioni C, et al. The
lung cancer breath signature: a comparative analysis of exhaled breath and air sampled
from inside the lungs. Sci Rep. 2015 Nov 12;5(1):16491.
9. Das S, Pal M. Review—Non-Invasive Monitoring of Human Health by Exhaled Breath
Analysis: A Comprehensive Review. J Electrochem Soc. 2020 Feb;167(3):037562.
10. Kischkel S, Miekisch W, Fuchs P, Schubert JK. Breath analysis during one-lung
ventilation in cancer patients. Eur Respir J. 2012 Sep;40(3):706–13.
11. Di Natale C, Macagnano A, Martinelli E, Paolesse R, D’Arcangelo G, Roscioni C, et al.
Lung cancer identification by the analysis of breath by means of an array of non-
selective gas sensors. Biosensors and Bioelectronics. 2003 Sep 1;18(10):1209–18.
12. Popov TA. Human exhaled breath analysis. Annals of Allergy, Asthma & Immunology.
2011 Jun 1;106(6):451–6.
13. Lawal O, Ahmed WM, Nijsen TME, Goodacre R, Fowler SJ. Exhaled breath analysis: a
review of ‘breath-taking’ methods for off-line analysis. Metabolomics. 2017;13(10):110.
14. Ahn JW, Pandey SK, Kim KH. Comparison of GC-MS calibration properties of volatile
organic compounds and relative quantification without calibration standards. Journal of
Chromatographic Science. 2011 Jan;49(1):19–28.
15. Janfaza S, Khorsand B, Nikkhah M, Zahiri J. Digging deeper into volatile organic
compounds associated with cancer. Biology Methods and Protocols [Internet]. 2019 Jan
1 [cited 2021 Oct 19];4(1). Available from: https://doi.org/10.1093/biomethods/bpz014
16. Poli D, Goldoni M, Corradi M, Acampa O, Carbognani P, Internullo E, et al.
Determination of aldehydes in exhaled breath of patients with lung cancer by means of
on-fiber-derivatisation SPME–GC/MS. Journal of Chromatography B. 2010 Oct
1;878(27):2643–51.
17. Barash O, Peled N, Tisch U, Bunn PA, Hirsch FR, Haick H. Classification of lung cancer
histology by gold nanoparticle sensors. Nanomedicine. 2012 Jul;8(5):580–9.
18. Ratiu IA, Ligor T, Bocos-Bintintan V, Mayhew CA, Buszewski B. Volatile Organic
Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD. J
Clin Med. 2020 Dec 24;10(1):32.
19. Peled N, Fuchs V, Kestenbaum EH, Oscar E, Bitran R. An Update on the Use of Exhaled
Breath Analysis for the Early Detection of Lung Cancer. LCTT. 2021 Aug 16;12:81–92.
20. Wu Y, Huo D, Hou C, Fa H, Yang M, Luo X. Colorimetric artificial nose for
identification of breath volatile organic compounds of patients with lung cancer. Chem
Res Chin Univ. 2014 Aug 1;30(4):572–7.
21. Zhong X, Li D, Du W, Yan M, Wang Y, Huo D, et al. Rapid recognition of volatile
organic compounds with colorimetric sensor arrays for lung cancer screening. Anal
Bioanal Chem. 2018 Jun;410(16):3671–81.
22. Steinbach J, Goedicke-Fritz S, Tutdibi E, Stutz R, Kaiser E, Meyer S, et al. Bedside
Measurement of Volatile Organic Compounds in the Atmosphere of Neonatal Incubators
Using Ion Mobility Spectrometry. Frontiers in Pediatrics. 2019;7:248.
23. Romero KI, Fernandez-Maestre R. Ion mobility spectrometry: the diagnostic tool of third
millennium medicine. Rev Assoc Med Bras (1992). 2018 Sep;64(9):861–8.
24. Montuschi P, Mores N, Trové A, Mondino C, Barnes PJ. The Electronic Nose in
Respiratory Medicine. RES. 2013;85(1):72–84.
25. Licht J-C, Grasemann H. Potential of the Electronic Nose for the Detection of
Respiratory Diseases with and without Infection. Int J Mol Sci. 2020 Dec
10;21(24):9416.
26. Mazzone PJ, Wang X-F, Xu Y, Mekhail T, Beukemann MC, Na J, et al. Exhaled Breath
Analysis with a Colorimetric Sensor Array for the Identification and Characterization of
Lung Cancer. J Thorac Oncol. 2012 Jan;7(1):137–42.
27. Trefz P, Kamysek S, Fuchs P, Sukul P, Schubert JK, Miekisch W. Drug detection in
breath: non-invasive assessment of illicit or pharmaceutical drugs. J Breath Res. 2017
Mar 20;11(2):024001.
28. McWilliams A, Beigi P, Srinidhi A, Lam S, MacAulay CE. Sex and Smoking Status
Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an
Electronic Nose. IEEE Trans Biomed Eng. 2015 Aug;62(8):2044–54.
29. Doty AC, Wilson AD, Forse LB, Risch TS. Assessment of the Portable C-320 Electronic
Nose for Discrimination of Nine Insectivorous Bat Species: Implications for Monitoring
White-Nose Syndrome. Biosensors (Basel). 2020 Feb 13;10(2):12.
30. Tirzïte M, Bukovskis M, Strazda G, Jurka N, Taivans I. Detection of lung cancer with
electronic nose and logistic regression analysis. J Breath Res. 2018 Nov
20;13(1):016006.
31. Jans H, Huo Q. Gold nanoparticle-enabled biological and chemical detection and
analysis. Chem Soc Rev. 2012 Mar 12;41(7):2849–66.
32. Amundsen T, Sundstrøm S, Buvik T, Gederaas OA, Haaverstad R. Can dogs smell lung
cancer? First study using exhaled breath and urine screening in unselected patients with
suspected lung cancer. Acta Oncologica. 2014 Mar 1;53(3):307–15.
33. Pleil J, Giese R. PERSPECTIVE Integrating exhaled breath diagnostics by disease-
sniffing dogs with instrumental laboratory analysis. J Breath Res. 2017 Sep
7;11(3):032001.
34. Feil C, Staib F, Berger MR, Stein T, Schmidtmann I, Forster A, et al. Sniffer dogs can
identify lung cancer patients from breath and urine samples. BMC Cancer. 2021 Aug
13;21(1):917.
35. Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G, et al. Canine scent
detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir
J. 2012 Mar;39(3):669–76.
36. Pirrone F, Albertini M. Olfactory detection of cancer by trained sniffer dogs: A
systematic review of the literature. Journal of Veterinary Behavior. 2017 May 1;19:105–
17.
37. Hackner K, Errhalt P, Mueller MR, Speiser M, Marzluf BA, Schulheim A, et al. Canine
scent detection for the diagnosis of lung cancer in a screening-like situation. J Breath
Res. 2016 Sep 27;10(4):046003.
38. Jezierski T, Walczak M, Ligor T, Rudnicka J, Buszewski B. Study of the art: canine
olfaction used for cancer detection on the basis of breath odour. Perspectives and
limitations. J Breath Res. 2015 May;9(2):027001.
39. Hunt J. Exhaled Breath Condensate—an overview. Immunol Allergy Clin North Am.
2007 Nov;27(4):587–v.
40. Konstantinidi EM, Lappas AS, Tzortzi AS, Behrakis PK. Exhaled Breath Condensate:
Technical and Diagnostic Aspects. ScientificWorldJournal. 2015;2015:435160.
41. Ahmadzai H, Huang S, Hettiarachchi R, Lin J-L, Thomas PS, Zhang Q. Exhaled breath
condensate: a comprehensive update. Clinical Chemistry and Laboratory Medicine. 2013
Jul 1;51(7):1343–61.
42. Bannier MAGE, Rosias PPR, Jöbsis Q, Dompeling E. Exhaled Breath Condensate in
Childhood Asthma: A Review and Current Perspective. Frontiers in Pediatrics.
2019;7:150.
43. Filipiak W, Filipiak A, Sponring A, Schmid T, Zelger B, Ager C, et al. Comparative
analyses of volatile organic compounds (VOCs) from patients, tumors and transformed
cell lines for the validation of lung cancer-derived breath markers. J Breath Res. 2014
May;8(2):027111.
44. Song G, Qin T, Liu H, Xu G-B, Pan Y-Y, Xiong F-X, et al. Quantitative breath analysis
of volatile organic compounds of lung cancer patients. Lung Cancer. 2010
Feb;67(2):227–31.
45. Oguma T, Nagaoka T, Kurahashi M, Kobayashi N, Yamamori S, Tsuji C, et al. Clinical
contributions of exhaled volatile organic compounds in the diagnosis of lung cancer.
PLoS One. 2017 Apr 6;12(4):e0174802.
46. Thriumani R, Zakaria A, Hashim YZH-Y, Jeffree AI, Helmy KM, Kamarudin LM, et al.
A study on volatile organic compounds emitted by in-vitro lung cancer cultured cells
using gas sensor array and SPME-GCMS. BMC Cancer. 2018 Apr 2;18(1):362.
47. Vries R de, Muller M, Noort V van der, Theelen WSME, Schouten RD, Hummelink K,
et al. Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung
cancer by electronic nose analysis of exhaled breath. Annals of Oncology. 2019 Oct
1;30(10):1660–6.
48. Shlomi D, Abud M, Liran O, Bar J, Gai-Mor N, Ilouze M, et al. Detection of Lung
Cancer and EGFR Mutation by Electronic Nose System. J Thorac Oncol. 2017
Oct;12(10):1544–51.
49. Ahmadzada T, Kao S, Reid G, Boyer M, Mahar A, Cooper WA. An Update on
Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer. J Clin
Med. 2018 Jun 15;7(6):153.
50. Nardi-Agmon I, Abud-Hawa M, Liran O, Gai-Mor N, Ilouze M, Onn A, et al. Exhaled
Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer.
Journal of Thoracic Oncology. 2016 Jun 1;11(6):827–37.
51. Broza YY, Kremer R, Tisch U, Gevorkyan A, Shiban A, Best LA, et al. A nanomaterial-
based breath test for short-term follow-up after lung tumor resection. Nanomedicine.
2013 Jan;9(1):15–21.
52. Poli D, Goldoni M, Caglieri A, Ceresa G, Acampa O, Carbognani P, et al. Breath
analysis in non small cell lung cancer patients after surgical tumour resection. Acta
Biomed. 2008;79 Suppl 1:64–72.
53. Phillips M, Altorki N, Austin JHM, Cameron RB, Cataneo RN, Kloss R, et al. Detection
of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta.
2008 Jul 17;393(2):76–84.
54. Chang JE, Lee DS, Ban SW, Oh J, Jung MY, Kim SH, et al. Analysis of volatile organic
compounds in exhaled breath for lung cancer diagnosis using a sensor system. Sensors
and Actuators, B: Chemical. 2018;255:800–7.
55. Das MK, Bishwal SC, Das A, Dabral D, Varshney A, Badireddy VK, et al. Investigation
of gender-specific exhaled breath volatome in humans by GCxGC-TOF-MS. Anal Chem.
2014 Jan 21;86(2):1229–37.

You might also like